2023
DOI: 10.1016/j.abd.2021.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Segmental hypopigmented acneiform nevus with FGFR2 gene mutation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 6 publications
0
0
0
Order By: Relevance
“…Patients with congenital fibroblast growth factor receptor 2 (FGFR2) gain-of-function mutations (S252W or P253R FGFR2)-either germline (Apert syndrome) [55][56][57][58] or segmental somatic (acne nevus of Munro) [59][60][61][62][63]-develop acne during puberty and respond to isotretinoin treatment [64]. FGFR2 is a tyrosine kinase receptor which, like INSR or IGF1R, activates multiple pathways, including PI3K/AKT signaling [55].…”
Section: Fgfr2-pi3k-akt-mediated Activation Of Mtorc1mentioning
confidence: 99%
“…Patients with congenital fibroblast growth factor receptor 2 (FGFR2) gain-of-function mutations (S252W or P253R FGFR2)-either germline (Apert syndrome) [55][56][57][58] or segmental somatic (acne nevus of Munro) [59][60][61][62][63]-develop acne during puberty and respond to isotretinoin treatment [64]. FGFR2 is a tyrosine kinase receptor which, like INSR or IGF1R, activates multiple pathways, including PI3K/AKT signaling [55].…”
Section: Fgfr2-pi3k-akt-mediated Activation Of Mtorc1mentioning
confidence: 99%